Fizazi, Ariane, Chris Serrand, Alexandre Evrard, Blanche Bergeret, Pierre-Emmanuel Stoebner, and Myriam Marque. “High BRAF V600 Mutation Level Associated With Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors”. Acta Dermato-Venereologica 104 (November 7, 2024): adv40913. Accessed April 29, 2026. https://medicaljournalssweden.se/actadv/article/view/40913.